is tirzepatide good for menopause The GLP-1/GIP dual-receptor agonist led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal hormone therapy had the greatest weight The role of menopause hormone

While tirzepatide's blood pressure effects are generally considered favorable, appropriate monitoring ensures safe implementation, particularly in individuals receiving concurrent antihypertensive therapy

These include lorcaserin, naltrexone/bupropion, phentermine/topiramate, orlistat, and the glucagon-like peptide-1 analogues liraglutide, and semaglutide

Be aware, however, that your doctor may notice the laboratory changes described throughout this article

Those are conversations for your healthcare provider, who knows your full medical history

Tirzepatide targets both GLP-1R and the glucose-dependent insulinotropic peptide receptor (GIPR), while the older two medications focus on GLP-1R alone

No discount games, no hidden fees